Paeoniflorin, the Main Active Ingredient of Shuyu Capsule, Inhibits Ca<sub>v</sub>1.2 and Regulates Calmodulin/Calmodulin-Dependent Protein Kinase II Signalling
Chunhong Song(Shandong University of Traditional Chinese Medicine), Mingqi Qiao(Shandong University of Traditional Chinese Medicine)
Cited by 15
Related Papers
Trends in Research Related to Premenstrual Syndrome and Premenstrual Dysphoric Disorder From 1945 to 2018: A Bibliometric Analysis
|Frontiers in Public Health|2021|45
Shuyu capsules relieve liver‑qi depression by regulating ERK‑CREB‑BDNF signal pathway in central nervous system of rat
|Experimental and Therapeutic Medicine|2017|29
Impact of anger emotional stress before pregnancy on adult male offspring
|Oncotarget|2017|10
Roles of the µ-opioid receptor and its related signaling pathways in the pathogenesis of premenstrual syndrome liver-qi stagnation
|Experimental and Therapeutic Medicine|2017|5